Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma

Targeted therapies, including BRAF and MEK inhibitors, are valuable treatment options for patients with unresectable or metastatic BRAF V600-mutant melanoma. With the improvement in survival seen with modern melanoma therapeutics, clinicians are learning the variable patterns associated with extende...

Descripción completa

Detalles Bibliográficos
Autores principales: Dar, Nakul, Gradecki, Sarah E., Gaughan, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495986/
https://www.ncbi.nlm.nih.gov/pubmed/37706179
http://dx.doi.org/10.3389/fonc.2023.1217179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495986/
https://www.ncbi.nlm.nih.gov/pubmed/37706179
http://dx.doi.org/10.3389/fonc.2023.1217179

Ejemplares similares